Literature DB >> 5107559

Gentamicin treatment of staphylococcal infections.

F Richards, C McCall, C Cox.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5107559

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

Review 1.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1972-06       Impact factor: 2.401

2.  Antibiotic susceptibility of oxacillin-resistant staphylococci.

Authors:  J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

3.  Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin.

Authors:  J Klastersky; C Hensgens; L Debusscher
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

4.  Treatment of septicaemia.

Authors: 
Journal:  Br Med J       Date:  1978-08-19

5.  Antibiotic activity in vitro against methicillin-resistant Staphylococcus epidermidis and therapy of an experimental infection.

Authors:  F D Lowy; J A Walsh; M M Mayers; R S Klein; N H Steigbigel
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

6.  Interaction of clindamycin and gentamicin in vitro.

Authors:  R J Fass; C A Rotilie; R B Prior
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

7.  Bacteriophage types and antibiotic susceptibility of Staphylococcus aureus.

Authors:  J Klastersky; J Beumer; D Daneau
Journal:  Appl Microbiol       Date:  1971-12

8.  Investigations of the occurrence of gentamicin-resistant Staphylococcus aureus.

Authors:  F J Buckwold; W L Albritton; A R Ronald; J Lertzman; R Henriksen
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

9.  Anti-staphylococcal activity resulting from epithelial lining fluid (ELF) concentrations of amikacin inhale administered via the pulmonary drug delivery system.

Authors:  Islam M Ghazi; Mordechai Grupper; David P Nicolau
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-01-17       Impact factor: 3.944

10.  The msaABCR Operon Regulates Persister Formation by Modulating Energy Metabolism in Staphylococcus aureus.

Authors:  Shanti Pandey; Gyan S Sahukhal; Mohamed O Elasri
Journal:  Front Microbiol       Date:  2021-04-14       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.